York biotech gains manufacturing approval in India

Biotech firm strikes research collaboration with Sheffield Uni
shutterstock.com / SUWIT NGAOKAEW

AIM-listed York biotech, OptiBiotix, has secured a license from regulators to manufacture its SlimBiome weight management product in India.

The approval, granted by the Foods Standards and Safety Authority India (FSSAI), was secured by OptiBiotix’s manufacturing partner, Zeon Life Sciences.

It covers both SlimBiome and products containing SlimBiome and follows the signing of a manufacturing and supply deal signed by both parties last month.

The FSSAI licence approval involves both ingredient and quality verification to ensure the product and manufacturing process is of a high standard and is an essential regulatory requirement to manufacture and distribute food products in India.

The licence approval allows Zeon to fulfil orders arising from OptiBiotix’s recent visit to India for SlimBiome and SlimBiome containing products in its own manufacturing site.

“Achieving FSSAI approval so quickly is a significant achievement and is an important step in completing the supply chain to meet the needs of existing and new corporate partners in India and Southern Asia,” said OptiBiotix CEO Stephen O’Hara.

“This agreement is another step in a strategy designed to build multiple revenue streams from ingredient sales, and white label and own label branded consumer and pharmaceutical products across multiple channels with industry partners from around the world.”